Screening, Assessment, and Pharmacologic Treatment of Mild Cognitive Impairment and Early Alzheimer’s Disease
The Primary Care Companion For CNS Disorders · 2023
DOI: 10.4088/pcc.23f03544 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Primary Care Companion For CNS Disorders, 2023. Verfasst von Marc S Weinberg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Massachusetts General Hospital, Boston. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Mental Disorders, Psychiatry. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Massachusetts General Hospital, Boston.
- Department of Neurology, Massachusetts General Hospital, Boston.
- Harvard Medical School, Boston, Massachusetts.
- Massachusetts General Hospital, Boston.
- Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts.
- McLean Hospital, Belmont, Massachusetts.
Zitieren
APA
Weinberg, M. S., Principe, J. L., Chen, A., Chung, S. Y., Arnold, S. E., & Stern, T. A. (2023). Screening, Assessment, and Pharmacologic Treatment of Mild Cognitive Impairment and Early Alzheimer’s Disease. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.23f03544
Vancouver
Weinberg MS, Principe JL, Chen A, Chung SY, Arnold SE, Stern TA. Screening, Assessment, and Pharmacologic Treatment of Mild Cognitive Impairment and Early Alzheimer’s Disease. The Primary Care Companion For CNS Disorders. 2023. doi:10.4088/pcc.23f03544
BibTeX
@article{Weinberg2023,
author = {Weinberg, Marc S and Principe, Jessica L and Chen, Anderson and Chung, Sun Young and Arnold, Steven E and Stern, Theodore A},
title = {Screening, Assessment, and Pharmacologic Treatment of Mild Cognitive Impairment and Early Alzheimer’s Disease},
journal = {The Primary Care Companion For CNS Disorders},
year = {2023},
doi = {10.4088/pcc.23f03544}
}
EUVIMED